Glycolysis gene expression analysis and selective metabolic advantage in the clinical progression of colorectal cancer.

Graziano, F; Ruzzo, A; Giacomini, E; Ricciardi, T; Aprile, G; Loupakis, F; Lorenzini, P; Ongaro, E; Zoratto, F; Catalano, V; Sarti, D; Rulli, E; Cremolini, C; De Nictolis, M; De Maglio, G; Falcone, A; Fiorentini, G; Magnani, M

Graziano, F; Ruzzo, A; Giacomini, E; Ricciardi, T; Aprile, G; Loupakis, F; Lorenzini, P; Ongaro, E; Zoratto, F; Catalano, V; Sarti, D; Rulli, E; Cremolini, C; De Nictolis, M; De Maglio, G; Falcone, A; Fiorentini, G; Magnani, M.

Graziano F; Department of Onco-Hematology, Azienda Ospedaliera "Ospedali Riuniti Marche Nord", Pesaro, Italy.
Ruzzo A; Department of Biomolecular Sciences, University of Urbino "Carlo Bo", Urbino, Italy.
Giacomini E; Department of Biomolecular Sciences, University of Urbino "Carlo Bo", Urbino, Italy.
Ricciardi T; Department of Biomolecular Sciences, University of Urbino "Carlo Bo", Urbino, Italy.
Aprile G; Department of Oncology, University Hospital of Udine, Udine, Italy.
Loupakis F; Department of Oncology, Azienda Ospdaliero-Universitaria Pisana, Pisa, Italy.
Lorenzini P; Institute of Histopathology, Azienda Ospedaliera "Ospedali Riuniti Marche Nord", Pesaro, Italy.
Ongaro E; Department of Oncology, University Hospital of Udine, Udine, Italy.
Zoratto F; Department of Oncology, Azienda Ospdaliero-Universitaria Pisana, Pisa, Italy.
Catalano V; Department of Onco-Hematology, Azienda Ospedaliera "Ospedali Riuniti Marche Nord", Pesaro, Italy.
Sarti D; Department of Onco-Hematology, Azienda Ospedaliera "Ospedali Riuniti Marche Nord", Pesaro, Italy.
Rulli E; Clinical Research Laboratory, IRCCS Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy.
Cremolini C; Department of Oncology, Azienda Ospdaliero-Universitaria Pisana, Pisa, Italy.
De Nictolis M; Institute of Histopathology, Azienda Ospedaliera "Ospedali Riuniti Marche Nord", Pesaro, Italy.
De Maglio G; Institute of Histopathology, University Hospital of Udine, Udine, Italy.
Falcone A; Department of Oncology, Azienda Ospdaliero-Universitaria Pisana, Pisa, Italy.
Fiorentini G; Department of Onco-Hematology, Azienda Ospedaliera "Ospedali Riuniti Marche Nord", Pesaro, Italy.
Magnani M; Department of Biomolecular Sciences, University of Urbino "Carlo Bo", Urbino, Italy.

Pharmacogenomics J ; 17(3): 258-264, 2017 06.

Article en En | MEDLINE | ID: mdl-26927284

Asunto(s)

Biomarcadores de Tumor/genética; Neoplasias Colorrectales/genética; Glucólisis/genética; Neoplasias Hepáticas/genética; Anciano; Inhibidores de la Angiogénesis/uso terapéutico; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico; Colectomía; Neoplasias Colorrectales/enzimología; Neoplasias Colorrectales/patología; Neoplasias Colorrectales/terapia; Progresión de la Enfermedad; Resistencia a Antineoplásicos/genética; Femenino; Perfilación de la Expresión Génica; Regulación Enzimológica de la Expresión Génica; Regulación Neoplásica de la Expresión Génica; Predisposición Genética a la Enfermedad; Hepatectomía; Humanos; Italia; Estimación de Kaplan-Meier; Neoplasias Hepáticas/enzimología; Neoplasias Hepáticas/secundario; Neoplasias Hepáticas/terapia; Masculino; Metastasectomía/métodos; Mutación; Farmacogenética; Variantes Farmacogenómicas; Fenotipo; ARN Mensajero/genética; Estudios Retrospectivos; Factores de Riesgo; Factores de Tiempo; Resultado del Tratamiento

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Biomarcadores de Tumor / Glucólisis / Neoplasias Hepáticas Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies País como asunto: Europa Idioma: En Año: 2017 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google